Cargando…
A quantitative metric of pioneer activity reveals that HNF4A has stronger in vivo pioneer activity than FOXA1
BACKGROUND: We and others have suggested that pioneer activity — a transcription factor’s (TF’s) ability to bind and open inaccessible loci — is not a qualitative trait limited to a select class of pioneer TFs. We hypothesize that most TFs display pioneering activity that depends on the TF concentra...
Autores principales: | Hansen, Jeffrey L., Cohen, Barak A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575205/ https://www.ncbi.nlm.nih.gov/pubmed/36253868 http://dx.doi.org/10.1186/s13059-022-02792-x |
Ejemplares similares
-
Pioneer of prostate cancer: past, present and the future of FOXA1
por: Teng, Mona, et al.
Publicado: (2020) -
Pioneer transcription factor FoxA is positioned on hypersensitive nucleosomes at active enhancers
por: Iwafuchi-Doi, Makiko, et al.
Publicado: (2013) -
FOXA1 mutations alter pioneering activity, differentiation, and prostate cancer phenotypes
por: Adams, Elizabeth J., et al.
Publicado: (2019) -
A test of the pioneer factor hypothesis using ectopic liver gene activation
por: Hansen, Jeffrey L, et al.
Publicado: (2022) -
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
por: Seachrist, Darcie D., et al.
Publicado: (2021)